1887

Abstract

In order to establish tumour-specific cytotoxic T lymphocyte (CTL) cell lines, T cells from a human papillomavirus (HPV) type 16-positive patient with a cervical carcinoma and from a healthy volunteer were stimulated with autologous dendritic cells loaded with peptides derived from the viral transforming proteins E6 and E7 and corresponding to potential HLA-A*0201-restricted T cell epitopes. From each donor a small number of low-affinity CTL lines against the peptide E7/86–93 was obtained, which specifically lysed HLA-A*0201-expressing B-lymphocytes (cell line 721) loaded with this peptide. Cytotoxicity was also observed against two HLA-A*0201-E7-positive epithelial cell lines, the cervical carcinoma cell line CaSki and the HPV-16-immortalized foreskin-keratinocyte cell line HPK IA. However, since none of the CTL recognized both cell lines, and E7-expressing 721 transfectants were never lysed, it was concluded that the reactivity against CaSki and HPK IA cells was due to cross-reactivity on allogeneic HLA molecules rather than to E7 recognition, which emphasizes that the specificity of tumour cell lysis by peptide-induced CTL has to be interpreted with caution.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-7-1689
1997-07-01
2022-05-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/7/9225046.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-7-1689&mimeType=html&fmt=ahah

References

  1. Auersperg N. 1964; Long-term cultivation of hypodiploid human tumor cells. Journal of the National Cancer Institute 32:135–163
    [Google Scholar]
  2. Bartholomew J. S., Stacey S., Coles B., Burt D., Arrand J. R., Stern P. L. 1994; Identification of a naturally processed HLA A*0201- restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. European Journal of Immunology 24:3175–3179
    [Google Scholar]
  3. Bednarek M., Sauma S. Y., Gammon M. C., Porter G., Tamhankar S., Williamson A. R., Zweerink H. J. 1991; The minimum peptide epitope from the influenza matrix protein. Extra- and intra-cellular loading of HLA-A2. Journal of Immunology 147:4047–4053
    [Google Scholar]
  4. Chen L., Thomas E. K., Hu S.-L., Hellström I., Hellström K. E. 1991; Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proceedings of the National Academy of Sciences USA: 88110–114
    [Google Scholar]
  5. Chen L., Mizuno M. T., Singhal M. C., Hu S. L., Galloway D. A., Hellström I., Hellström K. E. 1992; Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. Journal of Immunology 148:2617–2621
    [Google Scholar]
  6. Cromme F. V., Meijer C. J. L. M., Snijders P. J. F., Uyterlinde A., Kenemans P., Helmerhorst T., Stern P. L., van den Brule A. J. C., Walboomers J. M. M. 1993; Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. British Journal of Cancer 67:1372–1380
    [Google Scholar]
  7. de Gruijl T. D., Bontkes H. J., Stukart M. J., Walboomers J. M. M., Remmink A. J., Verheijen R. H. M., Helmerhorst T. J. M., Meijer C. J. L. M., Scheper R. J. 1996; T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with persistent viral infection. Journal of General Virology 77:2183–2191
    [Google Scholar]
  8. Dürst M., Dzarlieva Retrusevka R. T., Boukamp P., Fusenig N. E., Gissmann L. 1987; Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1:251–256
    [Google Scholar]
  9. Feltkamp M. C., Vreugdenhil G. R., Vierboom M. P. M., Ras E., van der Burg S. H., terSchegget J., Melief C. J. M., Kast W. M. 1995; Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. European Journal of Immunology 25:2638–2642
    [Google Scholar]
  10. Friedl F., Kimura I., Osato T., Ito Y. 1970; Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proceedings ofthe Societyfor Experimental Biology and Medicine 135:543–545
    [Google Scholar]
  11. Gunning P., Leavitt J., Muscat G., Ng S.-Y., Kedes L. 1987; A human-actin expression vector directs high-level accumulation of antisense transcripts. Proceedings of the National Academy of Sciences USA: 844831–4835
    [Google Scholar]
  12. Jenkins M. K., Taylor S. P., Norton S. D., Urdahl K. B. 1991; CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. Journal of Immunology 147:2461–2466
    [Google Scholar]
  13. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K. E., Seedorf K., Gissmann L. 1989; Antibodies against human papillomavirus type 16 early proteins in human sera: correlation between anti-E7 reactivity with cervical cancer. Journal ofthe National Cancer Institute 81:1698–1704
    [Google Scholar]
  14. Kadish A. S., Seymour L. R., Ledwidge R., Tindle R., Fernando G. J. P., Zee S. Y., Van Ranst M. A., Burk R. D. 1994; Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. Journal of General Virology 75:2277–2284
    [Google Scholar]
  15. Kast W. M., Brandt R. M. P., Sidney J., Drijfhout J.-W., Kubo R. T., Grey H. M., Melief C. J. M., Sette A. 1994; Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. Journal of Immunology 152:3904–3912
    [Google Scholar]
  16. Kavathas P., Bach F. H., DeMars R. 1980; Gamma ray induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proceedings of the National Academy of Sciences USA: 774251–4255
    [Google Scholar]
  17. Mansur C. P., Androphy E. J. 1993; Cellular transformation by papillomavirus oncoproteins. Biochimica et Biophysica Acta 1155:323–345
    [Google Scholar]
  18. Müller M., Viscidi R. P., Sun Y., Guerrero E., Hill P. M., Shah F., Bosch F. X., Munoz N., Gissmann L., Shah K. V. 1992; Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 187:508–514
    [Google Scholar]
  19. Patillo R. A., Hussa R. O., Story M. T., Ruckert A. C. F., Shalaby M. R., Mattingly R. F. 1977; Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196:1456–1458
    [Google Scholar]
  20. Plebanski M., Allsopp C. E. M., Aidoo M., Reyburn H., Hill A. V. S. 1994; Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. European Journal of Immunology 25:1783–1787
    [Google Scholar]
  21. Rammensee H.-G., Friede T., Stevanovic S. 1995; MHC liquids and peptide motifs first listing. Immunogenetics 41:178–228
    [Google Scholar]
  22. Ressing M. E., Sette A., Brandt R. M. P., Ruppert J., Wentworth P. A., Hartman M., Oseroff C., Grey H. M., Melief C. J. M., Kast W. M. 1995; Human CTL epitopes encoded by the human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. Journal of Immunology 154:5934–5943
    [Google Scholar]
  23. Ressing M. E., van Driel W. J., Celis E., Sette A., Brandt R. M. P., Hartman M., Anholts J. D. H., Schreuder G. M. T., terHarmsel W. B., Fleuren G. J., Trimbos B. J., Kast W. M., Melief C. J. M. 1996; Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope. Cancer Research 56:582–588
    [Google Scholar]
  24. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinmann R. M., Schuler G. 1994; Proliferating dendritic cell progenitors in human blood. Journal of Experimental Medicine 180:83–89
    [Google Scholar]
  25. Sadovnikova E., Zhu X., Collins S. M., Zhou J., Vousden K., Crawford L., Beverly P., Stauss H. J. 1994; Limitations of predictive motifs revealed by cytotoxic T Lymphocyte epitope mapping of the human papilloma virus E7 protein. International Immunology 6:289–296
    [Google Scholar]
  26. Salter R. D., Cresswell P. 1986; Impaired assembly and transport of the HLA-A and -B antigens in a mutant T × B cell hybrid. EMBOJournal 5:949–953
    [Google Scholar]
  27. Staerz U., Zepp F., Schmid R., Hill M., Rothbard J. 1989; Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide. European Journal of Immunology 19:2191–2196
    [Google Scholar]
  28. Tarpey I., Stacey S., Hickling J., Birley H. D. L., Renton A., Mclndoe A., Davies D. H. 1994; Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology 81:222–227
    [Google Scholar]
  29. van den Brule A. J. C., Claas E. C. J., du Maine M., Melchers W. J. G., Helmerhorst T., Quint W. G. V., Lindeman J., Meijer C. J. L. M., Walboomers J. M. M. 1989; Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. Journal of Medical Virology 29:20–27
    [Google Scholar]
  30. zur Hausen H. 1996; Papillomaviruses infections - a major cause of human cancers. Biochimica et Biophysica Acta 1288:F55–78
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-7-1689
Loading
/content/journal/jgv/10.1099/0022-1317-78-7-1689
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error